Deca 250 250mg/ml 10ml Vial by Master Pharma

Usage

1. Inspect the vial before every use: hold against a light source and rotate slowly — the solution should be clear to faintly yellow with no floating particles or colour change indicative of oxidation.
2. Warm the vial passively to 20–22 °C if stored at the lower end of the recommended range — gently rolling the vial between palms for 30 seconds reduces oil viscosity and ensures complete homogenisation without introducing air bubbles.
3. Swab the rubber stopper with a 70 % isopropyl alcohol swab and allow it to air-dry for a minimum of 30 seconds before needle insertion — do not blow on or fan the stopper to accelerate drying.
4. Use a fresh sterile needle of appropriate gauge (23–25 G, 1–1.5 inch for intramuscular sites) for every draw — never reuse a needle between draws even from the same vial.
5. Date the vial at first puncture with a permanent marker — the open-vial use period is 28 days; discard any remaining volume after this date regardless of quantity.
6. Return the vial promptly to its original carton and store at 15–25 °C away from light after each use — do not leave it on a windowsill, in a vehicle glove compartment, or near any heat source between injection days.

Warnings

Frequently asked questions

What is the correct storage temperature for Master Pharma Deca 250 before opening?

Store Deca 250 at 15–25 °C in a dark, dry location. Refrigeration is not required and is actively discouraged — oil-based injectables stored below 15 °C can develop visible oil crystallisation or cloudiness that does not necessarily indicate contamination but complicates accurate dosing and may alarm users unfamiliar with the phenomenon.

Does Nandrolone Decanoate in oil solution degrade if briefly exposed to light?

Brief light exposure during handling does not cause immediate degradation, but cumulative UV radiation measurably accelerates ester-bond cleavage over weeks. ICH Q1B photostability data for oil-based nandrolone formulations show that amber or opaque secondary packaging reduces UV-driven potency loss by more than 80 % across a 12-month period — keep the vial in its carton between uses.

How long can I use a Master Pharma Deca 250 10ml vial once the stopper has been punctured?

A punctured 10 ml vial of Deca 250 can be used safely for up to 28 days provided every draw uses a fresh sterile needle, the septum is swabbed with 70 % isopropyl alcohol and allowed to dry for at least 30 seconds before each puncture, and the vial is returned immediately to its 15–25 °C storage environment. Discard if the solution becomes cloudy, discoloured, or shows visible particulate.

Can I draw Deca 250 with an insulin syringe for precision microdosing?

At 250 mg/ml, a standard 1 ml insulin syringe calibrated in 0.01 ml increments allows doses as low as 25 mg (0.1 ml) to be measured with practical accuracy. Ensure the needle gauge is appropriate for intramuscular injection — insulin needles (29–31 G) are suitable only for subcutaneous administration; use at minimum a 25 G × 1 inch needle for intramuscular delivery of oil-based depots.

What happens if Deca 250 accidentally freezes during shipping?

Frozen oil-based injectables are recoverable in most cases: allow the vial to warm passively to room temperature (never use a microwave or direct heat source), then inspect for complete re-homogenisation before drawing. If crystalline or cloudy matter persists after 30 minutes at 20–22 °C, or if the stopper or vial shows signs of stress cracking, do not use the vial — contact the supplier with the batch number for a quality claim. (2) angle_used

Manufacturer

Master Pharma's approach to vial selection and secondary packaging reflects a deliberate engineering decision rather than a default commercial choice. For Deca 250, the 10 ml multi-dose vial format was selected over single-dose ampoules specifically because the decanoate ester's long active window means a single vial aligns naturally with a complete dosing cycle — and the aluminium-crimp-sealed bromobutyl stopper system is rated to maintain container-closure integrity across repeated puncture events when handled correctly. The stopper compound is validated for compatibility with oil-based parenteral matrices, confirmed through extractables and leachables assessment aligned with USP <661> container standards. Secondary carton construction incorporates light-blocking laminate to supplement the vial's primary amber-equivalent protection, and each carton is printed with a batch-specific code linking the unit to its Certificate of Analysis. This packaging architecture means the quality documentation travels with the product in a traceable, consumer-verifiable format from the Master Pharma fill-finish suite to the end user's storage environment.